Table 1.

Summary of rFVIIa treated cardiac surgery patients (CSP) who survived >4 hours

P#	Age sex	Procedure	Co-morbidities		Response to rFVIIa								Outcome
			CPB	EF%	Pre rFVIIa				Post rFVIIa
					R	P	F	C	R	P	F	C
1	75M	CABG	-	>45	18	18	8	10	0	4	0	0	Survived
13	36M	Aortic arch repair	+	>45	28	18	16	10	6	19	20	10	Died
14	64M	Aortic dissection	-	>45	39	37	32	50	2	6	4	0	Survived
17	63M	AVR/MVR repair	-	<25	7	18	16	15	1	12	6	0	Survived
18	70M	CABG	+	>25	6	20	20	20	0	0	0	0	Survived
20	72M	CABG	-	>25	21	12	10	0	0	0	0	0	Survived
24*	79M	CABG	+	>25	10	12	12	10	5	4	4	0	Died
27*	64M	CABG, IVAD	+	<25	30	30	33	20	28	16	28	20	Died
30	85M	CABG, ruptured aorta	+	>45	13	12	6	10	3	6	8	0	Died
32*	83M	CABG	+	>25	5	18	18	10	6	18	20	0	Died
33	78F	Ruptured aorta	+	<25	14	18	20	20	3	12	6	0	Died
35*	54M	Aortic arch repair	+	>45	9	6	18	10	15	24	12	20	Survived
Average					17	18	18	15	6	10	9	4
P value									.009	.038	.009	.03

P: Patient

R: Red Blood Cell; P: Platelet; F: Fresh Frozen Plasma; C: Cryoprecipitate

M: Male; F: Female

CPB: Cardiopulmonary Bypass

EF: Left Ventricular Ejection Fraction

CABG: Coronary Artery Bypass Graft

AVR: Aortic Valve Replacement

MVR: Mitral Valve Replacement

IVAD: Intraventricular Assisted Device

* Patient continued to require blood transfusion past 24 hours post rFVIIa treatment.